Peeling agents: toxicological and allergological aspects. 1999

N Cassano, and G Alessandrini, and M Mastrolonardo, and G A Vena
Department of Internal Medicine, Immunology an Infectious Diseases--Institute of Dermatology, University of Bari, Italy.

BACKGROUND The use of peeling agents is very common in clinical practice. However, despite the overall good safety profile, it is not without any inherent risk; therefore, clinicians should be adequately informed about potential risk in order to avoid or prevent them. OBJECTIVE This paper reviews toxicological and allergological aspects of peeling agents in general, also beyond their actual use in peeling procedures. Toxic and allergic reactions from peeling agents are rather uncommon and have been rarely reported in association with the medical use of peels. METHODS Systemic toxic effects may essentially derive from phenol and potentially from two phenol derivatives, resorcinol and salicylic acid. A complete understanding of the toxicological profile of peeling agents, along with a correct execution of the technique and a carefully selection of patients, can help avoid serious side effects. RESULTS Allergic contact reactions occur most frequently with resorcinol, while most peeling agents are only rare sensitizers or appear to be free of true sensitizing power. Other types of hypersensitivity response seem to be very rare.

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002615 Chemexfoliation Application of a cauterant to the skin for the purpose of causing a superficial destruction of the epidermis and upper layers of the dermis. After healing, the treated area has new epithelium. Chemical Face Peeling,Face Peeling, Chemical,Chemexfoliations
D005148 Facial Dermatoses Skin diseases involving the FACE. Favre-Racouchot Syndrome,Nodular Elastoidosis,Facial Dermatosis,Nodular Elastosis,Dermatoses, Facial,Dermatosis, Facial,Elastoidoses, Nodular,Elastoidosis, Nodular,Elastoses, Nodular,Elastosis, Nodular,Favre Racouchot Syndrome,Nodular Elastoidoses,Nodular Elastoses,Syndrome, Favre-Racouchot
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015595 Skin Aging The process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight. Photoaging of Skin,Skin Wrinkling,Solar Aging of Skin,Aging, Skin,Skin Wrinklings,Wrinkling, Skin
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D018570 Risk Assessment The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988) Assessment, Risk,Benefit-Risk Assessment,Risk Analysis,Risk-Benefit Assessment,Health Risk Assessment,Risks and Benefits,Analysis, Risk,Assessment, Benefit-Risk,Assessment, Health Risk,Assessment, Risk-Benefit,Benefit Risk Assessment,Benefit-Risk Assessments,Benefits and Risks,Health Risk Assessments,Risk Analyses,Risk Assessment, Health,Risk Assessments,Risk Benefit Assessment,Risk-Benefit Assessments

Related Publications

N Cassano, and G Alessandrini, and M Mastrolonardo, and G A Vena
January 1995, Dermatology (Basel, Switzerland),
N Cassano, and G Alessandrini, and M Mastrolonardo, and G A Vena
January 2013, Oxidative medicine and cellular longevity,
N Cassano, and G Alessandrini, and M Mastrolonardo, and G A Vena
April 1989, Journal of chromatography,
N Cassano, and G Alessandrini, and M Mastrolonardo, and G A Vena
May 1996, Cancer research,
N Cassano, and G Alessandrini, and M Mastrolonardo, and G A Vena
January 1986, The Annals of occupational hygiene,
N Cassano, and G Alessandrini, and M Mastrolonardo, and G A Vena
April 1968, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
N Cassano, and G Alessandrini, and M Mastrolonardo, and G A Vena
January 1981, Duodecim; laaketieteellinen aikakauskirja,
N Cassano, and G Alessandrini, and M Mastrolonardo, and G A Vena
January 1981, Acta dermato-venereologica. Supplementum,
N Cassano, and G Alessandrini, and M Mastrolonardo, and G A Vena
April 2017, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
N Cassano, and G Alessandrini, and M Mastrolonardo, and G A Vena
April 1981, Tijdschrift voor diergeneeskunde,
Copied contents to your clipboard!